These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28942445)

  • 1. Effect of Biodegradable Scleral Plugs Containing Curcumin on Proliferative Vitreoretinopathy.
    Zhang J; Zhou N; Zhang B; Ma J
    Ophthalmic Res; 2018; 59(1):30-36. PubMed ID: 28942445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye.
    Zhang J; Sun H; Zhou N; Zhang B; Ma J
    Curr Eye Res; 2017 Dec; 42(12):1597-1603. PubMed ID: 29111828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
    Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
    Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.
    Zhang X; Wei J; Ma P; Mu H; Wang A; Zhang L; Wu Z; Sun K
    J Pharm Pharmacol; 2015 Feb; 67(2):160-9. PubMed ID: 25557298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis.
    Sakurai E; Matsuda Y; Ozeki H; Kunou N; Nakajima K; Ogura Y
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2043-8. PubMed ID: 11481270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.
    Cardillo JA; Farah ME; Mitre J; Morales PH; Costa RA; Melo LA; Kuppermann B; Jorge R; Ashton P
    Br J Ophthalmol; 2004 Sep; 88(9):1201-5. PubMed ID: 15317716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy.
    Kuo HK; Chen YH; Wu PC; Kuo YH
    Ophthalmologica; 2015; 233(3-4):198-203. PubMed ID: 25721986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
    Peng YJ; Kau YC; Wen CW; Liu KS; Liu SJ
    J Biomed Mater Res A; 2010 Aug; 94(2):426-32. PubMed ID: 20186737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.
    Ozer MA; Polat N; Ozen S; Ogurel T; Parlakpinar H; Vardi N
    Int Ophthalmol; 2017 Jun; 37(3):599-605. PubMed ID: 27495951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable scleral plugs for vitreoretinal drug delivery.
    Yasukawa T; Kimura H; Tabata Y; Ogura Y
    Adv Drug Deliv Rev; 2001 Oct; 52(1):25-36. PubMed ID: 11672873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiproliferative effect of sustained drug delivery system of all-trans retinoic acid implant into rabbit's vitreous cavity for treatment of proliferative vitreoretinopathy].
    Yan XR; Dong XG; Chen N; Wang W
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):621-5. PubMed ID: 14766078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid.
    Dong X; Chen N; Xie L; Wang S
    Retina; 2006 Feb; 26(2):210-3. PubMed ID: 16467680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
    Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembling hydrogel loaded with 5-FU PLGA microspheres as a novel vitreous substitute for proliferative vitreoretinopathy.
    Yu Z; Ma S; Wu M; Cui H; Wu R; Chen S; Xu C; Lu X; Feng S
    J Biomed Mater Res A; 2020 Dec; 108(12):2435-2446. PubMed ID: 32419359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.
    Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA
    Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy.
    Turkoz Y; Er H; Borazan M; Yilmaz H; Mizrak B; Parlakpinar H; Cigremis Y
    Mediators Inflamm; 2004 Apr; 13(2):127-30. PubMed ID: 15203555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin.
    Kuo HK; Chen YH; Wu PC; Wu YC; Huang F; Kuo CW; Lo LH; Shiea J
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(6):3167-74. PubMed ID: 22491400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.